Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 2/20 | 0.76 |
| ▸ | ARG2 | P78540 | 4/20 | 0.67 |
| ▸ | ARG1 | P05089 | 3/20 | 0.67 |
| ▸ | NOS2 | P35228 | 6/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.59 |
| ▸ | GRM8 | O00222 | 1/20 | 0.59 |
| ▸ | GRM6 | O15303 | 1/20 | 0.59 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.59 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.59 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.59 |
| ▸ | GRM5 | P41594 | 1/20 | 0.59 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.59 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.59 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.59 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.59 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.59 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.59 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.59 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.59 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8893420 | 1.00 | GSR (0.76) | GSRARG2ARG1NOS2CYP1A2 | |
| SCHEMBL8894128 | 1.00 | GSR (0.76) | GSRARG2ARG1NOS2CYP1A2 | |
| SCHEMBL31348916 | 1.00 | GSR (0.76) | GSRARG2ARG1NOS2CYP1A2 | |
| SCHEMBL6741106 | 1.00 | GSR (0.76) | GSRARG2ARG1NOS2CYP1A2 | |
| SCHEMBL9829771 | 1.00 | GSR (0.76) | GSRARG2ARG1NOS2CYP1A2 | |
| Hydrochloric Acid SCHEMBL16599902 | 0.97 | GSR (0.73) | GSRARG2ARG1NOS2CYP1A2 | |
| Hydrochloric Acid SCHEMBL8892812 | 0.97 | GSR (0.73) | GSRARG2ARG1NOS2CYP1A2 | |
| SCHEMBL21689907 | 0.97 | GSR (0.80) | GSRARG2ARG1NOS2CYP1A2 | |
| SCHEMBL293201 | 0.97 | GSR (0.80) | GSRARG2ARG1NOS2CYP1A2 | |
| SCHEMBL29268443 | 0.97 | GSR (0.80) | GSRARG2ARG1NOS2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117476916-A | Coated modified sodium ion battery positive electrode material and preparation method thereof | 彭永进 | 2024-01-30 | — | — | CN | claimed |
| US-7427654-B1 | Degradable polymides | UNIVERSITY OF PUERTO RICO (US) | 2008-09-23 | — | — | US | claimed |
| EP-4719381-A1 | LIGAND-POLAR DRUG CONJUGATES | Tripartite Therapeutics Inc. (TW) | 2026-04-08 | — | — | EP | disclosed |
| CN-120365644-A | Corrosion-resistant anti-aging cable and preparation method thereof | 南京灏坤建筑材料有限公司 | 2025-07-25 | — | — | CN | disclosed |
| US-20250032635-A1 | LIGAND-POLAR DRUG CONJUGATES | TRIPARTITE THERAPEUTICS INC. (TW) | 2025-01-30 | — | — | US | disclosed |
| CN-117659771-A | High-solid-content nano water-based color paste and preparation method thereof | 江西三越新材料有限公司 | 2024-03-08 | — | — | CN | disclosed |
| CN-117476916-A | Coated modified sodium ion battery positive electrode material and preparation method thereof | 彭永进 | 2024-01-30 | — | — | CN | disclosed |
| US-10961427-B2 | Completion tools with fluid diffusion control layer | BAKER HUGHES, A GE COMPANY, LLC (US) | 2021-03-30 | — | — | US | disclosed |
| US-10738560-B2 | Packers having controlled swelling and methods of manufacturing thereof | BAKER HUGHES, A GE COMPANY, LLC (US) | 2020-08-11 | — | — | US | disclosed |
| US-20190092998-A1 | COMPLETION TOOLS WITH FLUID DIFFUSION CONTROL LAYER | BAKER HUGHES, A GE COMPANY, LLC (US) | 2019-03-28 | — | — | US | disclosed |
| US-20180305996-A1 | PACKERS HAVING CONTROLLED SWELLING AND METHODS OF MANUFACTURING THEREOF | BAKER HUGHES INCORPORATED (US) | 2018-10-25 | — | — | US | disclosed |
| US-7427654-B1 | Degradable polymides | UNIVERSITY OF PUERTO RICO (US) | 2008-09-23 | — | — | US | disclosed |
| US-5610141-A | CELL DIVISION STIMULANT | NYCOMED IMAGING AS (NO) | 1997-03-11 | — | — | US | disclosed |
| WO-1993024523-A1 | DOUBLE CHAIN PEPTIDE COMPOUNDS HAVING HEMOREGULATORY ACTIVITY | HAFSLUND NYCOMED AS (NO) | 1993-12-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250032635-A1 | LIGAND-POLAR DRUG CONJUGATES | CD274, SELPLG, PDCD1LG2 | GSR 3890/4885ARG2 1928/4885ARG1 1941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.